FDA updates ICU Medical tubing guidance after investigation
The October 5 update says affected tubing may continue to be used under normal clinical procedures; loose particles require action.
What the record says
FDA’s updated communication says ICU Medical’s investigation found the reported drip-chamber discoloration embedded in the PVC material, rather than entering the fluid path. The page says enhanced inspection recommendations from earlier communications are no longer recommended. Clinicians should follow intended use and facility procedures; individual devices with loose particulate matter in the fluid path should be segregated and reported to ICU Medical.
Source details and supporting locations.
Practical next step
Healthcare facilities should review the current FDA notice and manufacturer instructions for affected IV sets.
Limits and what is not established
This is a device correction with specific conditions, not a blanket statement that every IV device is unaffected. Patients should not change or handle infusion equipment based on this summary.
Sources checked October 12, 2026. Later notices may change instructions or arrangements.